Sign in to view content

ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa

Sunir J. Garg, MD, FACS, FASRS

Video
Published 2023

Related

Bevacizumab-First vs Real-World Cost Outcomes for Diabetic Macular Edema: 2-Year Cost Analysis Modeled on DRCR Protocol AC Results
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2023
Diabetic Retinopathy Telemedicine Outcomes With Artificial Intelligence-Based Image Analysis, Reflex Dilation, and Image Overread Protocol
Andrew J. Barkmeier, MD
Annual Meeting Talks
2021
Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021

Category: Diabetic Retinopathy

See more